【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 21
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 26
3.1.3 Prognosis and Quality of Life 28
3.2 Symptoms 29
3.2.1 Hemophilia A and B 29
3.2.2 Inhibitors 30
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 32
4.3 Global Trends 33
4.4 Forecast Methodology 35
4.4.1 Sources Used 35
4.4.2 Sources Not Used 36
4.4.3 Forecast Assumptions and Methods 37
4.5 Epidemiological Forecast for Hemophilia A (2014-2024) 41
4.5.1 Diagnosed Prevalent Cases of Hemophilia A 41
4.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 42
4.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 44
4.5.4 Age-Standardized Diagnosed Prevalence of Hemophilia A 46
4.6 Epidemiological Forecast for Hemophilia B (2014-2024) 47
4.6.1 Diagnosed Prevalent Cases of Hemophilia B 47
4.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 49
4.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 51
4.6.4 Age-Standardized Diagnosed Prevalence of Hemophilia B 53
4.7 Epidemiological Forecast for Hemophilia A and Hemophilia B (2014-2024) 54
4.7.1 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 54
4.7.2 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Sex 56
4.8 Discussion 58
4.8.1 Conclusions on Epidemiological Trends 58
4.8.2 Limitations of the Analysis 59
4.8.3 Strengths of the Analysis 60
5 Disease Management 61
5.1 Treatment Overview 61
5.1.1 Hemophilia A and B Diagnosis 61
5.1.2 Hemophilia A and B Treatment 62
5.1.3 Diagnosis of Inhibitors 64
5.1.4 Treatment of Inhibitors 65
5.2 US 67
5.2.1 Clinical Practice 67
5.3 France 69
5.3.1 Clinical Practice 69
5.4 Germany 71
5.4.1 Clinical Practice 71
5.5 Italy 73
5.5.1 Clinical Practice 73
5.6 Spain 75
5.6.1 Clinical Practice 75
5.7 UK 77
5.7.1 Clinical Practice 77
5.8 Japan 79
5.8.1 Clinical Practice 79
5.9 Argentina 81
5.9.1 Clinical Practice 81
6 Competitive Assessment 83
6.1 Overview 83
6.2 Strategic Competitive Assessment 83
6.3 Product Profiles – Hemophilia A 86
6.3.1 Advate (Octocog Alfa) 86
6.3.2 Kogenate FS/Helixate FS (Octocog Alfa) 92
6.3.3 Xyntha/ReFacto AF (Moroctocog Alfa) 99
6.3.4 Recombinate (Octocog Alfa) 103
6.3.5 Eloctate (Efmoroctocog Alfa) 107
6.3.6 NovoEight (Turoctocog Alfa) 113
6.3.7 Nuwiq (Simoctocog Alfa) 118
6.4 Product Profiles – Hemophilia B 123
6.4.1 BeneFIX (Nonacog Alfa) 123
6.4.2 Alprolix (Eftrenonacog Alfa) 128
6.4.3 Rixubis (Nonacog Gamma) 134
6.4.4 IXinity (Trenonacog Alfa) 138
6.5 Product Profiles – Hemophilia A and B with Inhibitors 143
6.5.1 NovoSeven RT (Eptacog Alfa) 143
7 Opportunity and Unmet Need 149
7.1 Overview 149
7.2 Opportunity Analysis 150
7.2.1 Longer-Lasting Recombinant Factors 150
7.2.2 Lower-Cost Recombinant Replacement Therapies 151
7.2.3 Lower Risk of Inhibitor Formation in Previously Untreated Patients 153
7.2.4 More Convenient Drug Administration 154
7.3 Unmet Needs Gap Analysis 154
7.3.1 Long-Acting FVIII Replacement Therapies 154
7.3.2 Gene Therapy Treatments for Hemophilia A and B 155
8 Pipeline Assessment 157
8.1 Overview 157
8.2 Late-Stage Development Candidates – Hemophilia A 158
8.2.1 Kovaltry (Octocog Alfa; BAY 81-8973) 159
8.2.2 Adynovate (BAX-855) 164
8.2.3 BAY 94-9027 (Damoctocog Alfa Pegol) 169
8.2.4 N8-GP (Turoctocog Alfa Pegol) 175
8.2.5 CSL-627 (rFVIII-SC) 181
8.2.6 GreenGene F (Beroctocog Alfa; GC1101C) 186
8.3 Late-Stage Development Candidates – Hemophilia B 192
8.3.1 CSL-654 (rIX-FP; Albutrepenonacog Alfa) 193
8.3.2 N9-GP (NN-7999; Nonacog Beta Pegol) 197
8.4 Late-Stage Development Candidates – Hemophilia A and B Bypassing Agents (Patients with Inhibitors) 203
8.4.1 BAX-817 (rFVIIa BI) 204
8.4.2 LR-769 (rhFVIIa) 209
8.4.3 CSL-689 (rVIIa-FP) 215
8.5 Promising Drugs in Early-Stage Development 220
8.5.1 Alternative Coagulation Promoters 220
8.5.2 Gene Therapies 223
9 Current and Future Players 227
9.1 Overview 227
9.2 Trends in Corporate Strategy 229
9.3 Company Profiles 229
9.3.1 Baxalta 229
9.3.2 Bayer 233
9.3.3 Biogen 235
9.3.4 CSL Behring 237
9.3.5 Novo Nordisk 239
9.3.6 Pfizer 242
10 Market Outlook 244
10.1 Global Markets 244
10.1.1 Forecast 244
10.1.2 Drivers and Barriers – Global Market 247
10.2 US 250
10.2.1 Forecast 250
10.2.2 Key Events 254
10.2.3 Drivers and Barriers 254
10.3 5EU 255
10.3.1 Forecast 255
10.3.2 Key Events 259
10.3.3 Drivers and Barriers – France 260
10.3.4 Drivers and Barriers – Germany 262
10.3.5 Drivers and Barriers – Italy 263
10.3.6 Drivers and Barriers – Spain 264
10.3.7 Drivers and Barriers – UK 265
10.4 Japan 266
10.4.1 Forecast 266
10.4.2 Key Events 270
10.4.3 Drivers and Barriers 270
10.5 Argentina 272
10.5.1 Forecast 272
10.5.2 Key Events 277
10.5.3 Drivers and Barriers 277
11 Appendix 279
11.1 Bibliography 279
11.2 Abbreviations 306
11.3 Methodology 309
11.4 Forecasting Methodology 309
11.4.1 Diagnosed Hemophilia Patients 309
11.4.2 Percent Drug-Treated Patients 310
11.4.3 Drugs Included in Each Therapeutic Class 310
11.4.4 Launch Dates 311
11.4.5 General Pricing Assumptions 312
11.4.6 Individual Drug Assumptions 313
11.4.7 Pricing of Pipeline Agents 322
11.5 Primary Research – KOLs Interviewed for this Report 323
11.6 Primary Research – Prescriber Survey 327
11.7 Real-World Data 327
11.8 About the Authors 329
11.8.1 Analyst 329
11.8.2 Therapy Area Director 329
11.8.3 Epidemiologists 329
11.8.4 Global Head of Healthcare 331
11.9 About GlobalData 332
11.10 Disclaimer 332
【レポート販売概要】
■ タイトル:血友病A・血友病Bの組換え因子補充療法:世界の薬剤市場予測・分析■ 英文:PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy - Global Drug Forecast and Market Analysis to 2024
■ 発行日:2015年12月
■ 調査会社:GlobalData
■ 商品コード:GDHC116PIDR
■ 調査対象地域:グローバル
- エンドポイント・セキュリティ・ソリューションの世界市場MarketsandMarkets forecast the endpoint security market size to grow from USD 11.62 Billion in 2015 to USD 17.38 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 8.4% from 2015 to 2020. The growing number of enterprise endpoints and consumer devices and access to critical data are creating a huge demand for endpoint security solutions across the world. The major factors driving the grow …
- 心臓ペースメーカー(医療機器)のグローバル新興国市場(2012-2018)BRICSS Cardiac Pacemakers market value is expected to reach US$903 million by 2016, primarily supported by the product types - Implantable Pacemakers and External Pacemakers. China accounts for nearly 27.5% of the market share and India claims more than 22.3%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Implantable Pac …
- 携帯電話用ケース及び機構部品製造の世界市場2015-2019About Mobile Phone Cases and Structural Parts Mobile phone cases and structural parts are the essential components of a mobile phone. Mobile phone manufacturers attach a high significance to the casing, as it forms an important factor for product differentiation and unique selling point. Consumers over the years have been looking at personalizing their mobile phones through different phone cases. …
- アジア太平洋のCOB(チップ・オン・ボード)LED市場2016-2020About Chip-On-Board (COB) LED Although the traditional surface-mounted device (SMD) LED light sources were energy efficient, they had disadvantages such as the lesser spread of lighting, glare effects, higher heat generation, and low lifespan. COB LEDs are advanced LED lighting sources in which many LEDs are packaged in a single module. These LEDs are manufactured using techniques such as wire bon …
- 世界のスマートサーモスタット市場(2014-2018)TechNavio’s analysts forecast the Global Smart Thermostats market will grow at a CAGR of 52.72 percent over the period 2013-2018. One of the key factors contributing to this market growth is the convenience of customers being able to control thermostats remotely. The Global Smart Thermostats market has also been witnessing an increase in the number of home energy management system companies. Howev …
- 鎮静作用(Sedation)の治療薬パイプライン動向(2015年上半期版)Sedation - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Sedation - Pipeline Review, H1 2015’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administr …
- インタラクティブ・キオスクの世界市場:ATM、セルフサービスキオスク、自動販売機Interactive kiosk is a system designed for public use to deliver information or enable transactions. It is a computer-like device that provides self-service access to products and services to the public in the places such as retail stores, airports, hospitals, school campuses, and government offices among others. According to MarketsandMarkets, the interactive kiosks market size is expected to gro …
- エネルギー管理システム(EMS)の世界市場分析:製品別(IEMS、BEMS、HEMS)、コンポーネント別(センサー、コントローラー、ソフトウェア、バッテリー、ディスプレイ装置)、業界別(電力・エネルギー、テレコム・IT、製造、小売・オフィス、ヘルスケア)、エンドユーザー別(住居用、商業用)、セグメント予測The global energy management system (EMS) market is expected to reach USD 72.73 billion by 2024, according to a new report by Grand View Research, Inc. Industries have primarily been using conventional energy monitoring systems. Cloud computing and big data are now changing the world of technology with their economic applications and better results. These technologies provide real-time data analyt …
- 世界の自動車クーラント市場2015The Global Automotive Coolant Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Coolant industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Coolant market analysis is provided for the international markets including development trends, competiti …
- サンドイッチの世界市場2016-2020About the Sandwiches Market A sandwich is defined as any form of bread with a filling. Traditional wedge sandwiches, as well as filled rolls, baguettes, bloomers, wraps, and bagels are some of the sandwiches available in the market. Around 57% of the commercially brought sandwiches are made with traditional square sandwich bread. Wraps account for about 5% of the overall sandwich sales. Technavio’ …
- 世界のDCモーター ドライブ市場(2014-2018)About DC Drives A drive is an adjustable speed device that regulates the speed and direction of motors. The adjustment is made by varying the current flow through the motor. Drives are classified into two broad categories based on the type of current: AC drives and DC drives. AC drives are used to control AC electric motors, while DC drives are used for DC electric motors. Drives are widely used i …
- サプライチェーン分析ソリューションの世界市場The businesses running in and across a huge plethora of verticals such as retail and consumer packaged goods, healthcare and life sciences, manufacturing, aerospace and defense, automotive, high tech and electronics, and others, require clear visibility in the entirety of the supply chain processes. Also, with the involvement of several huge steps and procedures in the complete supply chain of any …
- 急性喘息(Acute Asthma):世界の治験レビュー2014年下半期版Acute Asthma Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Asthma Global Clinical Trials Review, H2, 2014" provides data on the Acute Asthma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Asthma. It includes an overview of the trial numbers and their recruitment status as per the sit …
- レーザー加工の世界市場分析:製品別(ガス、ソリッドステート、ファイバー)、プロセス別(材料加工、マーキング、マイクロ加工)、用途別(自動車、航空宇宙、医療)、セグメント予測、2014-2025The global laser processing market is expected to reach USD 23 billion by 2025, according to a new report by Grand View Research, Inc. The rising utilization of expensive laser-drilling technique for oil & gas exploration purposes is projected to substitute the traditional techniques. Decreasing drilling costs are anticipated to increase the feasibility of uneconomic oil deposits; thus, positively …
- 世界の軍事弾薬市場動向2013-2023:主な開発プロジェクトThis report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Military Ammunition. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.